Skip to content

Organon OGN PP&E (Net)

PP&E (Net) at other companies

Pfizer logo
PfizerPFE
$19.4B+5.8%
Amgen logo
AmgenAMGN
$8.22B+23.0%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$2.13B+10.6%
Biogen logo
BiogenBIIB
$3.02B-3.7%
AbbVie logo
AbbVieABBV
$5.69B+8.6%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$444.61M+4.1%

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's PP&E (net)?
Organon (OGN) reported PP&E (net) of $1.28B in Q1 2026.
How has Organon's PP&E (net) changed year-over-year?
Organon's PP&E (net) increased by 6.9% year-over-year, from $1.2B to $1.28B.
What is the long-term trend for Organon's PP&E (net)?
Over 5 years (2020 to 2025), Organon's PP&E (net) has grown at a 5.8% compound annual growth rate (CAGR), from $984M to $1.3B.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.